[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![overnight_stock Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1941151648589434880.png) overnightstocks.com [@overnight_stock](/creator/twitter/overnight_stock) on x XXX followers
Created: 2025-07-22 08:18:58 UTC

China IND Filing Boosts $ZLAB +8.5% Pre-Market | via

Bristol Myers $BMS has submitted its first IND application in China for the investigational anti-CCR8 monoclonal antibody BMS-986340.

🧬 Why this boosts $ZLAB:
Zai Lab holds the China rights to BMS-986340 – this filing signals an imminent trial start, potential milestone payments, and future revenue participation in the lucrative oncology market.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947572062995800429/c:line.svg)

**Related Topics**
[bms](/topic/bms)
[$9688hk](/topic/$9688hk)
[$bms](/topic/$bms)
[$zlab](/topic/$zlab)
[china](/topic/china)
[$bmy](/topic/$bmy)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/overnight_stock/status/1947572062995800429)